Kumar Kaushik

Kumar Kaushik

Auto-generated profile, based on publicly available information

Kumar Kaushik

Centre for Fire Explosive and Environment Safety DRDO New Delhi India

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 March 2020 in Current Drug Targets
Verified
Journal Article
Closed access
PDF file
SDSweety Dahiya
Sweety Dahiya
ACAnil K. Chhillar
Anil K. Chhillar
NSNamita Sharma
Namita Sharma
PCPooja Choudhary
Pooja Choudhary
APAruna Punia
Aruna Punia
VPVirinder S. Parmar
Virinder S. Parmar
The existence of the multi-drug resistant (MDR) pathogenic fungus, Candida auris came to light in 2009. This particular organism is capable of causing nosocomial infections in immunecompromised persons. This pathogen is associated with consistent candidemia with high mortality rate and presents a serious global health threat. Whole genome sequence (WGS) investigation detected powerful phylogeographic Candida auris genotypes which are specialized to particular geological areas indicating dissemination of particular genotype among provinces. Furthermore, this organism frequently exhibits multidrug-resistance and displays an unusual sensitivity profile. Identification techniques that are commercialized to test Candida auris often show inconsistent results and this misidentification leads to treatment failure which complicates the management of candidiasis. Till date, Candida auris has been progressively recorded from several countries and therefore its preventive control measures are paramount to interrupt its transmission. In this review, we discussed prevalence, biology, drug-resistance phenomena, virulence factors and management of Candida auris infections.

4 July 2019 in RSC Advances
Verified
Journal Article
Open access
PDF file
SKSumit Kumar
Sumit Kumar
Lidong WuLidong Wu
Lidong Wu
NSNeha Sharma
Neha Sharma
AAAyushee Ayushee
Ayushee Ayushee
KKKumar Kaushik
Kumar Kaushik
Brijesh RathiBrijesh Rathi
Brijesh Rathi
Low-molecular weight organic gelators have been of significant interest in recent years because of their interesting properties and potential applications in sensing technology, biomedicine and drug delivery. Herein, the synthesis, characterization and gelation properties of new oseltamivir conjugates are reported. The oseltamivir–triazole conjugate 1 was synthesized via a click-reaction in a 75% yield. The key features of this conjugate include the presence of amide, flexible ester linkages and a triazole scaffold linking a hydrophobic alkyl chain. The conjugate 1, possessing a long alkyl chain, showed gelation properties in various apolar organic solvents. This gelation behavior was not observed in the case of the deesterified conjugate 2; this indicated the necessity of the alkyl chain for gelation. The gelator 1 showed thermoreversible gelation properties in a range of linear alkane solvents (from n-pentane to n-dodecane). A scanning electron microscopic study suggests that the gelator 1 exists as cross-linked structures, which are self-aggregated in the range of submicrometers, as supported by extensive 1H-NMR studies. The rheological parameters supported the occurrence of a soft gelation process, and the gel formed in n-decane was found to be stiffer than that formed in n-hexane. Computational studies suggested that the gelation behavior was indeed due to micelle formation and dependent on the lipophilicity of solvents.

30 October 2019 in Molecules
Verified
Journal Article
Open access
PDF file
YYYogesh Yadav
Yogesh Yadav
DSDeepti Sharma
Deepti Sharma
KKKumar Kaushik
Kumar Kaushik
VKVineet Kumar
Vineet Kumar
AJAmitabh Jha
Amitabh Jha
VPVirinder S. Parmar
Virinder S. Parmar
The synthesis of novel pyrazolylnucleosides 3a–e, 4a–e, 5a–e, and 6a–e are described. The structures of the regioisomers were elucidated by using extensive NMR studies. The pyrazolylnucleosides 5a–e and 6a–e were screened for anticancer activities on sixty human tumor cell lines. The compound 6e showed good activity against 39 cancer cell lines. In particular, it showed significant inhibition against the lung cancer cell line Hop-92 (GI50 9.3 µM) and breast cancer cell line HS 578T (GI50 3.0 µM).

4 August 2020 in Fire and Materials
Verified
Journal Article
Closed access
PDF file
TPTribhuvan Kumar Pathak
Tribhuvan Kumar Pathak
KKKumar Kaushik
Kumar Kaushik
SDSatya Prakash Dobhal
Satya Prakash Dobhal
PDPradeep Kumar Dixit
Pradeep Kumar Dixit
VSVandana Sharma
Vandana Sharma
RSRaj Pal Singh
Raj Pal Singh

6 January 2020 in New Journal of Chemistry
Verified
Journal Article
Closed access
PDF file
RRReeta Reeta
Reeta Reeta
RMRangarajan T. M.
Rangarajan T. M.
KKKumar Kaushik
Kumar Kaushik
RSRishi Pal Singh
Rishi Pal Singh
MSManjula Singh
Manjula Singh
REReeta
Reeta
A single method with a functionality switching option was developed for the first time for the Pd-catalyzed C–O cross-coupling of aryl bromides and bromo-chalcones with aldoximes. The ligand tBuXPhos (L2) was found to be an effective supporting ligand for the Pd-catalyzed coupling of aldoximes with bromo coupling partners. The functionality switching from oxime ethers to a phenolic or hydroxy group was driven by solvent or temperature. This method offers the products in good to excellent yields in short reaction times.